Efficacy and Safety Study of Nicotine Mint Lozenge (2mg and 4mg) in Smoking Cessation
Clinical trial NCT00985985 · COMPLETED
Trial details
- NCT number
- NCT00985985
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2011-03-01
- Enrollment
- 723
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.